Key result
Transfer for primary PCI yields ~2-fold higher odds of remaining symptom-free at 5 years vs. fibrinolysis.
Why the study?
The long-term prevalence of heart failure symptoms and angina pectoris after STEMI treated with primary PCI versus fibrinolysis was not well characterized.
RCT (n=850)
Randomized
Yes
Answers are grounded in this paper and cite their sources.
May favor transport for primary PCI in long-term symptom relief; leaves open confirmation in prospective STEMI trials.
AIMS: Subjective symptoms represent significant criteria of a patient's health condition; therefore, we focused on the long-term prevalence of heart failure symptoms and angina pectoris after myocardial infarction between two groups of patients in which two different therapeutic strategies were used during the acute phase of ST-elevation myocardial infarction (STEMI). METHODS: The PRAGUE-2 study enrolled 850 patients with STEMI. The patients were randomized into two groups - transport to a primary percutaneous coronary intervention (PCI) centre (n=429) vs. fibrinolysis in community hospitals (n=421). The data were collected from either primary hospitals or PCI centres, as well as via questionnaires. RESULTS: The mean follow-up was 58 months. At 5 years, 45.4% of patients were in New York Heart Association class I following primary PCI vs. 31.8% of those treated with fibrinolysis (OR 2.02, 95% CI 1.37-2.97, p<0.002). At 5 years, 83.6% of patients had no symptoms of angina pectoris following invasive therapy vs. 58% of patients treated with fibrinolysis (OR 4.47, 95% CI 2.79-7.18, p<0.001). CONCLUSIONS: The symptoms of angina pectoris and heart failure were significantly lower in patients assigned to primary PCI in the acute stage of myocardial infarction compared with patients treated with fibrinolysis at the 5-year follow up.
No takes yet. Share an insight, caveat, or question.
Bilkova et al. (2013) conducted an RCT in ST-elevation myocardial infarction (STEMI) (n=850). Transport to a primary percutaneous coronary intervention (PCI) centre vs. Fibrinolysis in community hospitals was evaluated on New York Heart Association (NYHA) class I at 5 years (OR 2.02, 95% CI 1.37-2.97, p=<0.002). Transportation for primary PCI increased the odds of being symptom-free (functional class I) at 5 years compared to fibrinolysis.
Synapse has enriched 10 related papers. Consider them for comparative context: